Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Dividends Paid - Common: 2017-2024

Historic Dividends Paid - Common for Fortress Biotech (FBIO) over the last 8 years, with Dec 2024 value amounting to $4.0 million.

  • Fortress Biotech's Dividends Paid - Common was N/A to $166,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year change of. This contributed to the annual value of $4.0 million for FY2024, which is 50.00% down from last year.
  • As of FY2024, Fortress Biotech's Dividends Paid - Common stood at $4.0 million, which was down 50.00% from $8.0 million recorded in FY2023.
  • Fortress Biotech's Dividends Paid - Common's 5-year high stood at $8.0 million during FY2023, with a 5-year trough of $4.0 million in FY2024.
  • Its 3-year average for Dividends Paid - Common is $6.7 million, with a median of $8.0 million in 2022.
  • Its Dividends Paid - Common has fluctuated over the past 5 years, first surged by 154.59% in 2020, then crashed by 50.00% in 2024.
  • Over the past 5 years, Fortress Biotech's Dividends Paid - Common (Yearly) stood at $6.5 million in 2020, then grew by 23.27% to $8.0 million in 2021, then remained steady at $8.0 million in 2022, then rose by 0.01% to $8.0 million in 2023, then slumped by 50.00% to $4.0 million in 2024.